Fosun Pharma (02196.HK) announced that its subsidiary, Fosun Pharma Singapore, has sold a total of 9.9 million shares of Gland Pharma through a bulk trade, accounting for 6.01% of its share capital, with a total consideration of approximately $211 million. The proceeds will be mainly used for supplementing working capital and repaying interest-bearing debt. After completion, the group will hold approximately 51.83% of Gland Pharma's equity.
復星醫藥(02196.HK)控股子公司減持Gland Pharma變現2.11億美元
Fosun Pharma's subsidiary, Shareholding Gland Pharma, realized $211 million through reduction of shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.